Publication | Closed Access

Comparison of insulin detemir and insulin glargine in a basal—bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial

NutritionType 1Diabetes ManagementInsulin GlargineInsulin ManagementDiabetesDiabetes ComplicationsDiabetes MellitusInsulin DeliveryInsulin DetemirMedicine